This document has been compiled by Drs Peter Young and Maryanne Mariyaselvam (Consultant Intensivist and Clinical Fellow, Queen Elizabeth Hospital, King’s Lynn) and the Oxford Academic Health Science Network (AHSN),… read more →
The IOFM Phase 1 Benchmarking Report shone light on a number of barriers to clinical adoption and was referenced in the NICE review of Medical Technology Guidance 3.
Sets out recommendations to speed up access to innovative healthcare and technologies, to improve efficiency and outcomes for NHS patients.
WireSafe is an engineered solution to prevent retention of the central line guidewires that are used when inserting large catheters into central veins.
The PneuX System is a cuffed ventilation tube and an electronic cuff monitoring and inflating device that prevents leakage of bacteria-laden oral and stomach contents to the lung. It has… read more →
An inventive NHS team in Kings Lynn has developed three innovations that have been demonstrated to improve patient safety in critical care. The Oxford AHSN is supporting the uptake of… read more →
Ventilator-associated pneumonia (VAP) can be defined as a pneumonia that occurs after more than 48 hours of intubation and mechanical ventilation. The incidence and mortality of VAP has been estimated… read more →
Ventilator-associated pneumonia (VAP) is the leading nosocomial cause of mortality in the intensive care unit (ICU). It also has substantial cost implications, extending ICU length of stay by at least… read more →
An innovative collaboration between the NHS and Bayer is supporting GPs in Buckinghamshire to prevent strokes in patients with atrial fibrillation (AF). The ‘Excellence in AF’ initiative, led by Oxford… read more →